Stock PDEX PRO-DEX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Pro-Dex, Inc.

Equities

PDEX

US74265M2052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-10 pm EDT 		5-day change 1st Jan Change
19.58 USD +0.51% Intraday chart for Pro-Dex, Inc. +0.26% +11.76%
May. 02 Earnings Flash (PDEX) PRO-DEX Reports Q3 Revenue $14.3M MT
May. 02 Earnings Flash (PDEX) PRO-DEX Posts Q3 EPS $0.19 MT

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • With an expected P/E ratio at 39.16 and 14.19 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
PRO-DEX, INC. Stock Pro-Dex, Inc.
+11.76% 66.95M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.34% 187B
C+
MEDTRONIC PLC Stock Medtronic plc
+0.92% 109B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-1.77% 69.22B
A
CENCORA, INC. Stock Cencora, Inc.
+14.21% 46.19B
B-
DEXCOM, INC. Stock DexCom, Inc.
-6.06% 46.36B
B-
HOYA CORPORATION Stock Hoya Corporation
+8.79% 42.44B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+19.03% 30.84B
B
TERUMO CORPORATION Stock Terumo Corporation
+19.36% 25.73B
A-
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-7.25% 23.22B
B
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PDEX Stock
  4. Ratings Pro-Dex, Inc.